AI

Alphabet Inc Portfolio holdings

AUM $2.14B
This Quarter Return
+51.28%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$2.14B
AUM Growth
+$2.14B
Cap. Flow
-$84.6M
Cap. Flow %
-3.96%
Top 10 Hldgs %
89.61%
Holding
40
New
Increased
Reduced
2
Closed
4

Top Buys

No buys this quarter

Sector Composition

1 Technology 55.72%
2 Healthcare 35.16%
3 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ASTS icon
1
AST SpaceMobile
ASTS
$13.1B
$418M 19.57%
8,943,486
ARM icon
2
Arm
ARM
$140B
$317M 14.85%
1,960,784
FRSH icon
3
Freshworks
FRSH
$3.84B
$242M 11.32%
16,206,643
PL icon
4
Planet Labs
PL
$2.02B
$195M 9.13%
31,942,641
RVMD icon
5
Revolution Medicines
RVMD
$7.39B
$152M 7.12%
4,133,277
MTSR
6
Metsera, Inc. Common Stock
MTSR
$3.8B
$141M 6.61%
4,961,744
VERV
7
DELISTED
Verve Therapeutics
VERV
$137M 6.4%
12,168,489
-180,597
-1% -$2.03M
GTLB icon
8
GitLab
GTLB
$7.88B
$123M 5.76%
2,724,712
TEM
9
Tempus AI, Inc. Class A Common Stock
TEM
$13.6B
$98.6M 4.62%
1,551,102
DXCM icon
10
DexCom
DXCM
$29.1B
$90.5M 4.24%
1,036,937
PATH icon
11
UiPath
PATH
$5.83B
$90M 4.22%
7,034,337
PRME icon
12
Prime Medicine
PRME
$556M
$37.2M 1.74%
15,062,498
MAZE
13
Maze Therapeutics, Inc. Common Stock
MAZE
$672M
$29.6M 1.39%
2,412,471
OSCR icon
14
Oscar Health
OSCR
$4.25B
$10.3M 0.48%
481,988
SANA icon
15
Sana Biotechnology
SANA
$721M
$7.68M 0.36%
2,812,500
GLUE icon
16
Monte Rosa Therapeutics
GLUE
$304M
$6.6M 0.31%
1,464,015
VERA icon
17
Vera Therapeutics
VERA
$1.44B
$5.68M 0.27%
241,264
BEAM icon
18
Beam Therapeutics
BEAM
$1.65B
$5.47M 0.26%
321,604
RLAY icon
19
Relay Therapeutics
RLAY
$631M
$5.43M 0.25%
1,568,753
DNTH icon
20
Dianthus Therapeutics
DNTH
$768M
$3.89M 0.18%
208,697
LYEL icon
21
Lyell Immunopharma
LYEL
$219M
$2.59M 0.12%
293,256
-5,571,869
-95% -$49.3M
SPRO icon
22
Spero Therapeutics
SPRO
$115M
$2.58M 0.12%
889,979
FHTX icon
23
Foghorn Therapeutics
FHTX
$298M
$2.35M 0.11%
500,901
WGS icon
24
GeneDx Holdings
WGS
$3.68B
$2.1M 0.1%
22,711
AUTL
25
Autolus Therapeutics
AUTL
$375M
$1.59M 0.07%
698,262